Articles, guides, and regulatory updates from our community.
New research explores antimicrobial peptide-functionalized nanoparticles activated by NIR light to fight biofilms in diabetic wounds. Learn what the study found.
By Peptide Association Research Team
A 2026 case report links long-acting growth hormone therapy to severe DKA in a teen without prior diabetes. Learn what the research means for patients.
By Peptide Association Research Team
New research explores how antimicrobial peptide-functionalized nanoparticles activated by near-infrared light may help eradicate biofilms in diabetic wounds.
By Peptide Association Research Team
A 2026 case report links long-acting growth hormone therapy to severe DKA in a child without prior diabetes. Learn what the research suggests for patient safety.
By Peptide Association Research Team
New research explores NIR-activated antimicrobial peptide nanoparticles that may help eradicate biofilms in diabetic wounds without promoting antibiotic resistance.
By Peptide Association Research Team
A 2026 case report links long-acting growth hormone therapy to severe DKA in a child without prior diabetes. Learn what clinicians and patients should know.
By Peptide Association Research Team
A 2026 case report reveals a child developed severe DKA after starting long-acting growth hormone therapy. Learn what clinicians and patients should know.
By Peptide Association Research Team
A landmark 2025 BMJ network meta-analysis comparing 19 obesity drugs across 262 trials reveals key trade-offs between weight loss, side effects, and heart health.
By Peptide Association Research Team
New research explores continuous spin-freeze-drying scale-out for PEGylated peptide formulations, showing consistent quality from lab to GMP manufacturing.
By Peptide Association Research Team
New research explores how continuous spin-freeze-drying for PEGylated peptide formulations can be scaled from lab to GMP-compatible production while maintaining quality.
By Peptide Association Research Team
New research explores antimicrobial peptide nanoparticles activated by near-infrared light to combat biofilm infections in diabetic wounds. Learn what the study found.
By Peptide Association Research Team
A landmark 2026 BMJ network meta-analysis of 262 trials compares 19 obesity drugs. See what researchers found about weight loss, harms, and cardiovascular outcomes.
By Peptide Association Research Team
New research shows continuous spin-freeze-drying of PEGylated peptides can scale to GMP manufacturing while maintaining product quality and stability.
By Peptide Association Research Team
New research explores continuous spin-freeze-drying scale-out for PEGylated peptides, showing consistent quality from lab to GMP production. Learn what this means.
By Peptide Association Research Team
New research suggests a biomimetic hematoma scaffold may enable ultra-low-dose BMP-2 to outperform standard bone repair methods. Learn what the study found.
By Peptide Association Research Team
A 2026 clinical study suggests HMB supplementation may support immune response and intracellular protein synthesis in critically ill ICU patients. Learn what researchers found.
By Peptide Association Research Team
New research shows continuous spin-freeze-drying can scale from lab to GMP manufacturing while preserving peptide quality. Learn what this means for patients.
By Peptide Association Research Team
New research explores scalable freeze-drying for PEGylated peptide formulations. Learn what this manufacturing breakthrough may mean for peptide therapy access.
By Peptide Association Research Team
New research reveals how telehealth rules, NP authority, and compounding infrastructure create major geographic gaps in peptide-based sexual medicine access.
By Peptide Association Research Team
A major 2026 BMJ network meta-analysis compared 19 obesity drugs across 262 trials. See what the evidence shows about benefits, harms, and trade-offs.
By Peptide Association Research Team
New research explores how DNA methylation and the Wnt signaling pathway may influence Alzheimer's disease progression linked to insulin resistance.
By Peptide Association Research Team
A 2026 study reveals significant geographic disparities in access to peptide-based sexual medicine therapies driven by state-level healthcare policies.
By Peptide Association Research Team
A major 2025 BMJ network meta-analysis compared 19 obesity drugs across 262 trials. See what researchers found about benefits, risks, and tradeoffs.
By Peptide Association Research Team
New research finds where you live—not just federal policy—may determine your access to peptide-based sexual medicine therapies. Here's what the data shows.
By Peptide Association Research Team